longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HKEX-R

80388

338.0000.06% ( -0.200 )
Delay Closed: Sep 16, 16:08:46
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

HKEX-R (80388)

Hong Kong Exchanges and Clearing Limited, together with its subsidiaries, owns and operates stock and futures exchanges, and related clearing houses in Hong Kon...

Open
338.200
High
338.200
Low
337.200
Prev. Close
338.200
Volume
600
Turnover
202.56K
Avg Price
337.600
Bid/Ask Ratio
77.78%
Amplitude
0.30%
52wk High
408.879
Volume Ratio
0.07
Turnover Ratio
0.00%
52wk Low
306.016
HK Mkt Cap
428.53B
Market CapCNY
428.53B
P/ETTM
24.91
P/EDynamic
23.34
P/EStatic
--
EPSTTM
13.57
EPSDynamic
14.48
EPSStatic
--
BVPS
41.55
P/B
8.13
HK Shares
1.27B
Dividend YieldTTM
3.60%
DividendTTM
12.169
Shares
1.27B
Min lot size
100
Currency
CNY

HKEX-R Analyst Rating

View more

Forecast & Rating

Jul 10, 2026
Price forecast
HK$431.0027.51%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%
Strong buy
1
Buy
0
Hold
0
Sell
0
Strong sell
0

News

  • Jul 20 at 08:31 AM

    BABA Qwen 3.8 challenges Fable 5; Tencent doubles down on embodied AI | Daily News Recap

  • Global Report · Jul 9 at 10:03 AM

    The Split Screen of Hong Kong in 2026: From Tencent's AI Ambitions to Kaisa's Survival

  • Jun 29 at 08:29 AM

    XPEV MONA L03 set for Jul 2 debut; Kunlunxin reportedly seeking $50bn IPO, topping BIDU | Daily News Recap

  • Apr 28 at 08:28 AM

    CATL's discounted equity raise rattles market; Tencent Cloud up for a third straight session YTD | Daily News Recap

  • Feb 3 at 08:26 AM

    Tax-hike rumors rattled the market; Dongpeng Beverage's debut was 'lukewarm' | Daily News Recap

  • Jan 9 at 08:27 AM

    TSM Q4 rev. seen >NT$1 tn; GOOGL integrates Gemini into Gmail | Daily News Recap

Posts

View more

Bullish vs. Bearish — Last 3 Months

500 followers · 0 opinions
CHLND
▲Bullish50%
50%Bearish▼
  • N
    NewUser_oPJWOUAug 20 at 10:21 AM

    The 3 local banks have stabilised a little following the previous few days of down sessions for the whole SG market. This is good for the longer scheme of things as historical statistics show that steep rise s n share prices are more likely than not followed by steep drawbacks afterwards. Let them consolidate, though I know many are still buying either for long term or just trying to jump on bandwagon.

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Moderna Soars 177% on Landmark Cancer Vaccine Win

    Moderna had its best day ever Wednesday: shares soared 177% after its melanoma vaccine, developed with Merck, became the first mRNA cancer therapy to succeed in a Phase 3 trial. Merck rose alongside i...

  • D
    dingdongbellRate Of ReturnAug 20 at 06:59 AM

    Yay! US has shown their intent and are telling the bond market not to have ideas as they will defend yields no matter what FUD the narratives are.

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Moderna Soars 177% on Landmark Cancer Vaccine Win

    Moderna had its best day ever Wednesday: shares soared 177% after its melanoma vaccine, developed with Merck, became the first mRNA cancer therapy to succeed in a Phase 3 trial. Merck rose alongside i...

  • N
    NewUser_ThinkSwimAug 20 at 05:04 AM

    Modena stock not certain if its a pump and dump after the news and upside yesterday but generally if you want to invest in healthcare or even in the bio field can consider etf with Modena in it for long term investment. Do not all in money, DCA slowly and see if its temporary demand and expectations issues.

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Moderna Soars 177% on Landmark Cancer Vaccine Win

    Moderna had its best day ever Wednesday: shares soared 177% after its melanoma vaccine, developed with Merck, became the first mRNA cancer therapy to succeed in a Phase 3 trial. Merck rose alongside i...